Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
177.85
+2.21 (1.26%)
Nov 19, 2024, 4:00 PM EST - Market closed
Krystal Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Net Income | 52.37 | 10.93 | -139.98 | -69.57 | -32.17 | -19.09 | Upgrade
|
Depreciation & Amortization | 4.08 | 5.01 | 4.06 | 2.77 | 1.85 | 1.09 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.03 | -99.97 | 0.07 | - | 0.03 | 0.07 | Upgrade
|
Loss (Gain) From Sale of Investments | -5.58 | -5.09 | -0.57 | - | - | - | Upgrade
|
Stock-Based Compensation | 45.62 | 39.93 | 33.23 | 15.32 | 3.27 | 1.24 | Upgrade
|
Other Operating Activities | 1.01 | -1.73 | -0.19 | 1.04 | 0.01 | - | Upgrade
|
Change in Accounts Receivable | -87.98 | -42.04 | - | - | - | - | Upgrade
|
Change in Inventory | -5.88 | -4.48 | - | - | - | - | Upgrade
|
Change in Accounts Payable | 1.38 | -0.1 | -1.25 | 0.71 | 0.78 | -0.2 | Upgrade
|
Change in Other Net Operating Assets | 58.3 | 8.73 | 4.07 | 1.79 | 0.13 | -1.8 | Upgrade
|
Operating Cash Flow | 63.35 | -88.8 | -100.57 | -47.94 | -26.08 | -18.69 | Upgrade
|
Capital Expenditures | -5.28 | -11.8 | -52.98 | -68.34 | -14.84 | -6.4 | Upgrade
|
Sale of Property, Plant & Equipment | - | 100 | - | - | - | - | Upgrade
|
Investment in Securities | -84.54 | -5.56 | -61.1 | -158.43 | 3.66 | 1.41 | Upgrade
|
Investing Cash Flow | -89.82 | 82.64 | -114.08 | -226.77 | -11.18 | -4.99 | Upgrade
|
Issuance of Common Stock | 32.59 | 203.5 | 36 | 355.65 | 118.02 | 107.53 | Upgrade
|
Repurchase of Common Stock | -5.39 | -0.75 | -0.65 | - | - | - | Upgrade
|
Other Financing Activities | - | - | - | -7.96 | - | - | Upgrade
|
Financing Cash Flow | 27.21 | 202.75 | 35.35 | 347.69 | 118.02 | 107.53 | Upgrade
|
Foreign Exchange Rate Adjustments | -0 | -0.16 | -0.04 | - | - | - | Upgrade
|
Net Cash Flow | 0.73 | 196.43 | -179.35 | 72.98 | 80.76 | 83.84 | Upgrade
|
Free Cash Flow | 58.06 | -100.6 | -153.55 | -116.27 | -40.93 | -25.09 | Upgrade
|
Free Cash Flow Margin | 24.04% | -198.43% | - | - | - | - | Upgrade
|
Free Cash Flow Per Share | 1.97 | -3.63 | -6.02 | -5.24 | -2.18 | -1.58 | Upgrade
|
Levered Free Cash Flow | 42.38 | -74.41 | -89.35 | -85.35 | -19.98 | -18.93 | Upgrade
|
Unlevered Free Cash Flow | 42.38 | -74.41 | -89.35 | -84.41 | -19.98 | -18.93 | Upgrade
|
Change in Net Working Capital | 42.63 | 46.79 | -2.15 | -9.51 | -10.37 | 1.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.